Company intelligence / Profile preview

MindMend Biotech LLC

Grand Forks, North Dakota, United Statesmindmendbio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

MindMend Biotech LLC, founded in 2023 by PhD students at the University of North Dakota, develops innovative biotechnology solutions targeting complex neurological and mental health challenges. The company focuses on bridging engineering innovation with clinical application to improve outcomes for patients with neurodegenerative diseases. No clinical results or late-stage programs are publicly reported as of May 2025[1][2].

Therapeutic areas: PsychiatryNeurology
Modalities: Not explicitly stated; likely includes digital health tools and biotechnology solutions for neurological and mental health disorders[1][2][3].
Industry: Biotech

Beyond the preview

Go deeper on MindMend Biotech LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindMend Biotech LLC.

Explore the full profile